AI Article Synopsis
Article Abstract
The number and the size of the Langerhans islets in the pancreata of most of investigated cases with diabetic foetopathy is increased (polynesia and macronesia). The B endocrine cells are immunoreactive for both insulin and IAPP, the reaction for IAPP being weaker in comparison with the controls. In one of the cases (the mother with long history of treated type 1 diabetes, who died during delivery) no presence of insulin-immunoreactive of PAF positive B cells is discovered. The reactivity for glucagon and somatostatin in the pancreata with diabetic foetopathy is found to be similar to the controls. In the vicinity of some islets lymphoid cell infiltrations are observed.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Clinical implications of the glucokinase impaired function - GCK MODY today.
Physiol Res
December 2020
Department of Pediatrics, Medical Faculty of the Comenius University, Bratislava, Slovakia.
Heterozygous inactivating mutations of the glucokinase (GCK) gene are causing GCK-MODY, one of the most common forms of the Maturity Onset Diabetes of the Young (MODY). GCK-MODY is characterized by fasting hyperglycemia without apparent worsening with aging and low risk for chronic vascular complications. Despite the mild clinical course, GCK-MODY could be misdiagnosed as type 1 or type 2 diabetes.
View Article and Find Full Text PDF[Changes in hemostasis and fibrinolysis in gestational diabetes].
Cas Lek Cesk
February 1996
Oddĕlení klinické hematologie a II. gynekologicko-porodnická klinika 1. LF UF a VFN, Praha.
Background: The most serious complication of diabetes is the progressive development of vascular changes in which impaired hemocoagulation and fibrinolysis participate. The latter were investigated in diabetes type 1 and 2, but les is known about them in gestational diabetes (GDM). The objective of the submitted work was to assess wither these disorders occur also during GDM and to compare the assessed changes of haemostasis and fibrinolysis with findings in a) non-pregnant healthy controls (n = 58), b) healthy pregnant women (n = 41) and c) groups of pregnant women with impaired haemostasis during gestation/gestational hemorrhage (n = 15), preeclampsia (n = 22), varicosities (n = 15) and dead foetus syndrome (n = 16), but normal carbohydrate metabolism.
View Article and Find Full Text PDF[Immunohistochemical studies of the pancreas in newborns with diabetic fetopathy].
Akush Ginekol (Sofiia)
December 1996
The number and the size of the Langerhans islets in the pancreata of most of investigated cases with diabetic foetopathy is increased (polynesia and macronesia). The B endocrine cells are immunoreactive for both insulin and IAPP, the reaction for IAPP being weaker in comparison with the controls. In one of the cases (the mother with long history of treated type 1 diabetes, who died during delivery) no presence of insulin-immunoreactive of PAF positive B cells is discovered.
View Article and Find Full Text PDFAn analysis of the dependence of embryonic pathology development on heliocosmic factors is conducted and regular changes of the appearance of different kinds of pathology depending on heliocosmic situations in different months of the year are shown. Periods of conception of increasing amount of children with different disturbances of development coincide with values of the Wolf's number and sun-radiation stream density of certain ranges in comparison with the mean values, the same indexes are in conformity with the periods of conception of children having haemolytic disease and diabetic foetopathy.
View Article and Find Full Text PDF[Somatic and psychomotor development of children of diabetic mothers in the 4th year in relation to neonatal findings].
Arztl Jugendkd
July 1992
Abteilung Neonatologie, Ernst-Moritz-Arndt-Universität Greifswald.
340 infants of mothers with type I diabetes (IDM) were examined during the neonatal period for gestational age, somatic data and clinical symptoms of diabetogenic foetopathy and assigned to one of three groups: group I--those whose weight development was delayed or appropriate for gestational age and without symptoms of foetopathy; group II--neonates who were overweight or of appropriate weight for their gestational age and who showed clear symptoms of foetopathy; group III--macrosomic infants (weight and length in advance of gestational age) without any major symptoms of foetopathy. In a pilot study preparing for more comprehensive follow up, 20 children from each group were examined in their fourth year to check their psychomotor and somatic development. To evaluate their growth additional data obtained on IDMs by correspondence were included.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!